Equities
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.32
  • Today's Change0.025 / 1.94%
  • Shares traded30.42m
  • 1 Year change-26.12%
  • Beta2.1258
Data delayed at least 15 minutes, as of Nov 21 2024 20:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.

  • Revenue in USD (TTM)812.04m
  • Net income in USD-212.62m
  • Incorporated2018
  • Employees2.65k
  • Location
    Tilray Brands Inc655 Madison Avenue, 19Th FloorNEW YORK 10065United StatesUSA
  • Phone+1 (416) 934-2141
  • Fax+1 (416) 934-2141
  • Websitehttps://www.tilray.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
TLRY:NSQ since
announced
Transaction
value
Revolver Brewing LLCDeal completed13 Aug 202413 Aug 2024Deal completed-26.12%--
Terrapin Beer CoDeal completed13 Aug 202413 Aug 2024Deal completed-26.12%--
Hop Valley Brewing CoDeal completed13 Aug 202413 Aug 2024Deal completed-26.12%--
Data delayed at least 15 minutes, as of Nov 21 2024 20:59 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Elite Pharmaceuticals Inc66.45m19.58m708.80m64.0034.6812.1733.6610.670.01910.01910.0640.05450.98922.914.981,038,252.0029.1519.0736.1824.2945.2746.6329.4720.772.091.440.13890.0065.7949.55464.56--111.50--
Pliant Therapeutics Inc0.00-201.68m774.67m158.00--2.24-----3.34-3.340.005.680.00----0.00-40.90-33.24-43.90-35.39-------360.29----0.0802---83.69---30.83---16.89--
Avid Bioservices Inc142.36m-144.17m781.54m371.00--13.29--5.49-2.27-2.272.240.91920.36613.814.32383,714.30-37.08-0.826-57.59-1.206.2719.26-101.27-2.141.05-3.180.7343---6.2721.15-54,444.79--84.15--
Pacira Biosciences Inc694.96m-90.73m786.33m711.00--1.05--1.13-2.15-2.1513.0316.240.45481.717.03977,436.00-5.943.35-6.833.9874.3572.63-13.068.571.89--0.43930.001.2214.88163.72--0.8761--
Evolus Inc248.33m-55.46m799.75m322.00--135.63--3.22-0.9141-0.91414.110.09311.254.596.61909,619.10-27.90-40.92-38.48-59.7469.9465.43-22.33-80.462.23-2.040.9537--35.98--17.10--182.77--
Liquidia Corp15.61m-119.48m850.07m136.00--7.74--54.46-1.62-1.620.21111.310.0857--4.14114,779.40-65.55-55.02-75.02-62.6964.6582.18-765.37-474.596.33-31.140.5059--9.7545.23-91.40--66.93--
Phibro Animal Health Corp1.05bn17.41m947.38m1.94k54.493.6617.640.90510.42930.429325.826.381.082.606.75539,568.101.803.932.204.9031.4731.181.663.771.692.200.647256.454.074.21-92.59-46.356.650.8548
Collegium Pharmaceutical Inc599.25m88.59m967.51m197.0015.004.134.091.612.002.0013.057.270.42616.252.923,041,853.006.302.799.384.8062.3650.8814.785.160.88323.940.78730.0022.1715.11292.60---54.77--
Avadel Pharmaceuticals PLC (ADR)138.16m-72.58m1.03bn154.00--13.87--7.49-0.7894-0.78941.480.7750.76471.046.38897,142.90-40.17-40.21-54.87-47.9991.92---52.53-374.752.60-6.110.00-----22.99-16.59------
ANI Pharmaceuticals Inc555.46m-8.77m1.16bn642.00--2.8622.452.09-0.4489-0.448928.6720.440.51021.752.96865,196.30-0.6514-2.83-0.7654-3.3559.7960.18-1.28-6.151.970.70180.5921--53.8719.28131.250.17549.08--
Tilray Brands Inc812.04m-212.62m1.17bn2.65k--0.3247--1.43-0.2746-0.27461.033.970.18752.318.73306,429.10-4.64---5.15--29.42---24.78--1.57-1.160.0953--25.80--83.14------
Innoviva Inc352.75m64.59m1.20bn112.0027.841.7911.483.400.68790.68794.7810.680.29161.144.443,149,509.005.3426.245.9828.5387.93--18.3176.841.641.930.4011---6.303.53-15.99-14.57----
Ocular Therapeutix Inc61.44m-174.34m1.37bn267.00--3.91--22.28-1.30-1.300.44422.250.18832.482.28230,116.10-53.42-46.70-59.98-54.1890.5989.36-283.75-228.6512.94-27.520.1615--13.4996.60-13.65--26.37--
Harrow Inc169.14m-33.41m1.51bn315.00--26.07--8.90-0.9408-0.94084.761.630.53054.864.69536,946.10-10.48-10.86-12.74-12.7172.5670.75-19.75-15.351.44-0.35290.7635--46.9525.77-73.30--143.88--
Immunocore Holdings PLC - ADR296.55m-47.11m1.62bn497.00--4.29--5.47-0.9494-0.94945.887.550.35930.5415.68596,681.90-5.71-27.55-7.45-36.8299.38---15.89-97.123.76--0.5373--43.0551.23-5.22--2.85--
Data as of Nov 21 2024. Currency figures normalised to Tilray Brands Inc's reporting currency: US Dollar USD

Institutional shareholders

5.13%Per cent of shares held by top holders
HolderShares% Held
Tidal Investments LLCas of 30 Sep 20249.71m1.08%
Morgan Stanley & Co. LLCas of 30 Sep 20248.79m0.97%
Susquehanna Financial Group LLLPas of 30 Sep 20247.62m0.84%
Highbridge Capital Management LLCas of 30 Sep 20245.19m0.58%
Global X Investments Canada, Inc.as of 31 Oct 20243.23m0.36%
The Vanguard Group, Inc.as of 30 Sep 20243.21m0.36%
Aristeia Capital LLCas of 30 Sep 20242.44m0.27%
BMO Asset Management, Inc.as of 30 Sep 20242.17m0.24%
Invesco Capital Management LLCas of 30 Sep 20242.03m0.22%
Geode Capital Management LLCas of 30 Sep 20242.00m0.22%
More ▼
Data from 30 Sep 2024 - 14 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.